These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38426575)

  • 21. Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
    Trifiletti DM; Smith A; Mitra N; Grover S; Lukens JN; Cohen RB; Read P; Mendenhall WM; Lin A; Swisher-McClure S
    J Clin Oncol; 2017 May; 35(14):1550-1560. PubMed ID: 28475848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
    Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved survival with definitive chemoradiation compared to definitive radiation alone in squamous cell carcinoma of the vulva: A review of the National Cancer Database.
    Rao YJ; Chin RI; Hui C; Mutch DG; Powell MA; Schwarz JK; Grigsby PW; Markovina S
    Gynecol Oncol; 2017 Sep; 146(3):572-579. PubMed ID: 28662775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer.
    Kelly JR; Park HS; An Y; Yarbrough WG; Contessa JN; Decker R; Mehra S; Judson BL; Burtness B; Husain Z
    Oral Oncol; 2018 Apr; 79():64-70. PubMed ID: 29598952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
    Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
    [No Abstract]   [Full Text] [Related]  

  • 26. A Consideration for Surgical Management in Select T4b Oral Cavity Squamous Cell Carcinoma.
    Chen MM; Chang CM; Dermody S; Rosko AJ; Mierzwa ML; Swiecicki PL; Spector ME; Worden FP; Prince MEP; Chinn SB
    Ann Otol Rhinol Laryngol; 2022 Jun; 131(6):609-616. PubMed ID: 34365858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Surgical Margin Status in Patients With Salivary Gland Cancer.
    Hanson M; McGill M; Mimica X; Eagan A; Hay A; Wu J; Cohen MA; Patel SG; Ganly I
    JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):128-138. PubMed ID: 34854898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients.
    Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A
    Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
    Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
    Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Adjuvant Radiotherapy for Malignant Salivary Gland Tumors.
    Safdieh J; Givi B; Osborn V; Lederman A; Schwartz D; Schreiber D
    Otolaryngol Head Neck Surg; 2017 Dec; 157(6):988-994. PubMed ID: 28675085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy.
    Cho JK; Lim BW; Kim EH; Ko YH; Oh D; Noh JM; Ahn YC; Baek KH; Jeong HS
    Ann Surg Oncol; 2016 Dec; 23(13):4368-4375. PubMed ID: 27342828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparities in Postoperative Therapy for Salivary Gland Adenoid Cystic Carcinomas.
    Cassidy RJ; Switchenko JM; El-Deiry MW; Belcher RH; Zhong J; Steuer CE; Saba NF; McDonald MW; Yu DS; Gillespie TW; Beitler JJ
    Laryngoscope; 2019 Feb; 129(2):377-386. PubMed ID: 30194768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
    Fischer-Valuck BW; Rao YJ; Henke LE; Rudra S; Hui C; Baumann BC; Gay HA; Michalski JM
    Eur Urol Focus; 2018 Dec; 4(6):900-906. PubMed ID: 28919521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of Positive Margins After Definitive Resection for Gastric Adenocarcinoma and Impact of Adjuvant Therapies.
    Rhome RM; Moshier E; Sarpel U; Ohri N; Mazumdar M; Buckstein MH
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1106-1115. PubMed ID: 28721894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
    Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
    Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies.
    Rosenberg L; Weissler M; Hayes DN; Shockley W; Zanation A; Rosenman J; Chera B
    Head Neck; 2012 Jun; 34(6):872-6. PubMed ID: 22127998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.
    Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.